Castle Biosciences, Inc. (CSTL) NASDAQ
19.71
-1.26(-6.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
19.71
-1.26(-6.01%)
Currency In USD
| Market Cap | 1.13B |
| Enterprise Value | 1.05B |
| P/E Ratio | -45.91 |
| PEG Ratio | 0.46 |
| Price/Sales Ratio | 1.76 |
| Price/Book Ratio | 1.28 |
| Enterprise/Revenue | 1.68 |
| Enterprise/EBITDA | -119.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.04 |
| Operating Margin | -0.1 |
| Return On Assets | -0.02 |
| Return On Equity | -0.03 |
| Revenue | 344.23M |
| Revenue/Share | 11.37 |
| Gross Profit | 273.2M |
| EBITDA | 11.34M |
| Net Income | -24.16M |
| Diluted EPS | -0.83 |
| Total Cash | 261.69M |
| Total Cash/Share | 8.76 |
| Total Debt | 36.72M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 6.75 |
| Book Value Per Share | 15.44 |
| 52-Week Change | 21.14 |
| 52-Week High | 44.28 |
| 52-Week Low | 14.59 |
| Moving Average 50 Days | 22.88 |
| Moving Average 200 Days | 28.75 |
| Average Volume | 383,249 |
| Shares Outstanding | 30.33M |
| % Held by Institutions | 94.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |